← FDA Drug Approvals (Drugs@FDA)

LATANOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2025-12-17

Drug application

FDA Application #

ANDA220360

Application type

Abbreviated New Drug Application (Generic)

Brand name

LATANOPROST

Generic name

LATANOPROST OPHTHALMIC SOLUTION

Active ingredients

LATANOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

MANKIND PHARMA

Manufacturer

Lifestar Pharma LLC

First approval

2025-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown